(Total Views: 749)
Posted On: 04/11/2022 7:01:41 PM
Post# of 154804
hallelujah closetinvestor even posted some good cydy news:
One piece of good news from the 10q: DSMC recommended the COVID trial in Brazil continue. CYDY has sent the recommendation to ANVISA to get the trial enrolling again
“April 2022, the DSMB for the Brazilian COVID-19 clinical trials met and recommended that the Brazilian COVID-19 trials, previously paused by the Company, may continue based on the review of the interim patient safety data from the clinical trials. The Company is in the process of providing this information to ANVISA for their subsequent review of the information prior to commencing the enrollment of new patients in the Brazilian trials”.
One piece of good news from the 10q: DSMC recommended the COVID trial in Brazil continue. CYDY has sent the recommendation to ANVISA to get the trial enrolling again
“April 2022, the DSMB for the Brazilian COVID-19 clinical trials met and recommended that the Brazilian COVID-19 trials, previously paused by the Company, may continue based on the review of the interim patient safety data from the clinical trials. The Company is in the process of providing this information to ANVISA for their subsequent review of the information prior to commencing the enrollment of new patients in the Brazilian trials”.
(4)
(0)
